Journal of the National Cancer Institute

Articles Available on Medscape

• Menopausal Hormone Therapy and Breast Cancer
  Recent results from hormone therapy trials have substantially changed concepts regarding how estrogen alone and estrogen plus progestin influence breast cancer.

  May 15, 2012

• Network Meta-analysis of Margin Threshold for Women With Ductal Carcinoma In Situ
  Negative margins are associated with reduced risk of recurrence for women with DCIS who are treated with breast-conserving surgery, but what is the minimum margin width?

  May 08, 2012

• Effects of Angiopoietin-2-blocking Antibody on Endothelial Cell-Cell Junctions and Lung Metastasis
  Does blocking Ang2 inhibits metastatic dissemination by enhancing the integrity of endothelial cell-cell junctions?

  April 30, 2012

• CYP2D6 Genotype as a Marker for Benefit of Adjuvant Tamoxifen in Postmenopausal Women
  In this editorial, 2 breast cancer specialists comment on 2 studies that apparently refute the utility of CYP2D6 as a marker for the benefit of tamoxifen. Why has such a good theory gone wrong?

  April 24, 2012

• Quality of Life, Fertility Concerns, and Behavioral Health Outcomes in Younger Breast Cancer Survivors
  Cancer treatments in younger women may cause premature menopause, infertility, and negative psychosocial effects. How can these be minimized?

  April 17, 2012

More

Journal of the National Cancer Institute's Latest Table of Contents

2012 - 104 (9)

• Staging and Functional Characterization of Pheochromocytoma and Paraganglioma by 18F-Fluorodeoxyglucose (18F-FDG) Positron Emission Tomography. 

  May 02, 2012

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Getting It Right: BPA and the Difficulty Proving Environmental Cancer Risks. 

  May 02, 2012

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• StatBite Age-Specific Mammography Screening Results. 

  May 02, 2012

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Physician Data Query (PDQ(R)) Update. 

  May 02, 2012

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• The promise of protons in cancer therapy. 

  May 02, 2012

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Macrophages: Cancer Therapy's Double-Edged Sword. 

  May 02, 2012

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Molecular scores to predict ovarian cancer outcomes: a worthy goal, but not ready for prime time. 

  May 02, 2012

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• A DNA repair pathway-focused score for prediction of outcomes in ovarian cancer treated with platinum-based chemotherapy. 

  May 02, 2012

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Vitamin d-related genetic variation, plasma vitamin d, and risk of lethal prostate cancer: a prospective nested case-control study. 

  May 02, 2012

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Risk of breast cancer after false-positive test results in screening mammography. 

  May 02, 2012

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• CYP3A Variation, Premenopausal Estrone Levels, and Breast Cancer Risk. 

  May 02, 2012

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Unraveling genes, hormones, and breast cancer. 

  May 02, 2012

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Effects of Gut-Targeted 15-LOX-1 Transgene Expression on Colonic Tumorigenesis in Mice. 

  May 02, 2012

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Is 15-LOX-1 a Tumor Suppressor? 

  May 02, 2012

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Re: potential pitfalls of crossover and thoughts on iniparib in triple-negative breast cancer. 

  May 02, 2012

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Re: novel therapies for metastatic castrate-resistant prostate cancer. 

  May 02, 2012

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]